← Evidence map

TrialMedicine2020

Metronomic capecitabine as maintenance treatment after first line induction with XELOX for metastatic colorectal cancer patients.

Rui Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33371122